S. Wagner

发表

High-throughput oncogene mutation profiling in human cancer

S. Gabriel, S. Nelson, M. Meyerson, 2007, Nature Genetics.

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

T. Golub, G. Getz, M. Meyerson, 2005, Nature.

Involvement of chemokine receptors in breast cancer metastasis

T. Mcclanahan, S. Wagner, Nianfeng Ge, 2001, Nature.

A Landscape of Driver Mutations in Melanoma

A. Sivachenko, K. Cibulskis, S. Gabriel, 2012, Cell.

Gene Expression Changes in an Animal Melanoma Model Correlate with Aggressiveness of Human Melanoma Metastases

J. Mesirov, Jean-Philippe Brunet, A. Subramanian, 2008, Molecular Cancer Research.

Melanoma genome sequencing reveals frequent PREX2 mutations

T. Fennell, A. Sivachenko, K. Cibulskis, 2012, Nature.

Signal Sequence Receptor 2 is required for survival of human melanoma cells as part of an unfolded protein response to endoplasmic reticulum stress.

S. Wagner, B. Garg, G. Pathria, 2016, Mutagenesis.

NVP-LDE225, a Potent and Selective SMOOTHENED Antagonist Reduces Melanoma Growth In Vitro and In Vivo

K. Mertz, S. Wagner, G. Stingl, 2013, PloS one.

Differential downregulation of endoplasmic reticulum-residing chaperones calnexin and calreticulin in human metastatic melanoma.

S. Wagner, M. Busch, J. Dissemond, 2004, Cancer letters.

Comprehensive comparative and semiquantitative proteome of a very low number of native and matched epstein-barr-virus-transformed B lymphocytes infiltrating human melanoma.

K. Bennett, S. Wagner, J. Colinge, 2014, Journal of proteome research.

B cells sustain inflammation and improve survival in human melanoma

K. Mertz, S. Wagner, M. Herlyn, 2018, bioRxiv.

Comparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene

L. Chin, W. Hahn, C. Brennan, 2006, Cell.

Combination of an EGFR blocker and a COX‐2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma

S. Wagner, G. Stingl, A. Jalili, 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Neuroendocrine neoplasms of the lung are not associated with point mutations at codon 12 of the Ki-ras gene

H. Höfler, S. Wagner, B. Pütz, 1993, Virchows Archiv. B, Cell pathology including molecular pathology.

Downregulation of tapasin expression in progressive human malignant melanoma

S. Wagner, J. Dissemond, M. Goos, 2003, Archives of Dermatological Research.

CpG motifs are efficient adjuvants for DNA cancer vaccines.

S. Wagner, G. Stingl, Anja Zemann, 2004, The Journal of investigative dermatology.

Development of a DNA Vaccine Againts Malignant Melanoma

S. Wagner, K. Moelling, C. Döhring, 1997 .

Analysis of Pmel17/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy

S. Wagner, C. Wagner, M. Goos, 1997, Cancer Immunology, Immunotherapy.

Differential expression of tissue inhibitor of metalloproteinases-2 by cutaneous squamous and basal cell carcinomas.

H. Soyer, S. Wagner, H. Ockenfels, 1996, The Journal of investigative dermatology.

TYPE‐1 PLASMINOGEN ACTIVATOR INHIBITOR IN HUMAN RENAL CELL CARCINOMA

H. Höfler, S. Wagner, M. Schmitt, 1996, The Journal of pathology.

Management of malignant melanoma: new developments in immune and gene therapy

S. Wagner, G. Stingl, A. Schneeberger, 2000, Clinical and experimental dermatology.

Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma.

H. Höfler, S. Wagner, M. Schmitt, 1995, The American journal of pathology.

Intracutaneous genetic immunization with autologous melanoma-associated antigen Pmel17/gp100 induces T cell-mediated tumor protection in vivo.

S. Wagner, G. Stingl, C. Wagner, 2000, The Journal of investigative dermatology.

Induction of Specific Immune Responses by Polycation-Based Vaccines1

S. Wagner, W. Schmidt, M. Buschle, 2002, The Journal of Immunology.

A Peptide to Reduce Pulmonary Edema in a Rat Model of Lung Transplantation

S. Wagner, M. Schultz, D. Wiedemann, 2015, PloS one.

Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma

S. Wagner, C. Willers, H. Grosse-wilde, 2000, The Lancet.

γδ T-cell lymphoma mimicking Sézary syndrome.

S. Wagner, W. Bauer, R. Knobler, 2012, Acta dermato-venereologica.

Inhibition of T cell cAMP formation by cyclosporin A and FK506

S. Wagner, K. Jakobs, H. Ockenfels, 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

Expression of Stromelysin 3 in the Stromal Elements of Human Basal Cell Carcinoma

S. Wagner, M. Atkinson, M. Goos, 1992, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney

H. Höfler, S. Wagner, M. Schmitt, 2005, Histochemistry and Cell Biology.

Single-cell RNA sequencing analyses of primary cutaneous B-cell disorders reveal distinct molecular patterns consistent with clinical behavior

S. Wagner, J. Griss, M. Farlik, 2022, bioRxiv.

Occupational UVA-induced allergic photodermatitis in a welder due to hydrochlorothiazide and ramipril.

S. Wagner, M. Goos, F. Welke, 2000, Contact dermatitis.

Unbalanced overexpression of the mutant allele in murine Patched mutants.

M. Rosemann, S. Wagner, R. Kappler, 2002, Carcinogenesis.

Melanoma--new developments in diagnosis and therapy.

S. Wagner, A. Schneeberger, Wagner Sn, 2003, Cancer chemotherapy and biological response modifiers.

Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells

G. Superti-Furga, S. Wagner, B. Garg, 2016, Cell Death and Disease.

Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma

T. Golub, Jean-Philippe Brunet, S. Ramaswamy, 2012, Journal of the National Cancer Institute.

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon α, and interleukin 2

D. Schadendorf, J. Becker, S. Wagner, 2002, British Journal of Cancer.

B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma

Johannes Griss, Christoph Bock, Martin Simon, 2019, Nature Communications.

Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.

K. Mertz, S. Wagner, I. Wolf, 2016, Human pathology.

Molecular Strategies Interfering with Tumor Progression of Melanoma and Improving Anti-Tumor Immunity

S. Wagner, G. Stingl, A. Schneeberger, 2001 .

Loss of Lymphotoxin Alpha-Expressing Memory B Cells Correlates with Metastasis of Human Primary Melanoma

K. Mertz, S. Wagner, J. Griss, 2021, Diagnostics.

A Standardized Analysis of Tertiary Lymphoid Structures in Human Melanoma: Disease Progression- and Tumor Site-Associated Changes With Germinal Center Alteration

K. Mertz, S. Wagner, J. Griss, 2021, Frontiers in Immunology.

Spatiotemporal Analysis of B Cell- and Antibody Secreting Cell-Subsets in Human Melanoma Reveals Metastasis-, Tumor Stage-, and Age-Associated Dynamics

K. Mertz, S. Wagner, J. Griss, 2021, Frontiers in Cell and Developmental Biology.

Integrative Genome Comparison of Primary and Metastatic Melanomas

L. Chin, S. Ramaswamy, Yonghong Xiao, 2010, PloS one.

MTSS1 is a metastasis driver in a subset of human melanomas

L. Chin, A. Sboner, K. Mertz, 2014, Nature Communications.

An Attempt at a Molecular Prediction of Metastasis in Patients with Primary Cutaneous Melanoma

S. Wagner, I. Wolf, J. Wenzel, 2012, PloS one.

Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence.

Benjamin G. Bitler, S. Wagner, M. Herlyn, 2013, Cell reports.

Expression cloning of the cDNA encoding a melanoma-associated Ag recognized by mAb HMB-45. Identification as melanocyte-specific Pmel 17 cDNA.

H. Höfler, S. Wagner, M. Atkinson, 1995, Laboratory investigation; a journal of technical methods and pathology.

Tumor-associated B-cells induce tumor heterogeneity and therapy resistance

Johannes Griss, Zhi Wei, Jie Zhang, 2017, Nature Communications.

Digital image analysis improves precision of PD‐L1 scoring in cutaneous melanoma

Johannes Griss, Werner Kempf, Gieri Cathomas, 2018, Histopathology.

Growth factors and oncogenes as targets in melanoma: lost in translation?

L. Chin, S. Wagner, L. Kwong, 2007, Advances in dermatology.

Polo-like kinase 1 is a potential therapeutic target in human melanoma.

S. Ramaswamy, S. Wagner, G. Stingl, 2011, The Journal of investigative dermatology.

A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)

A. Enk, S. Wagner, H. Lehr, 2005, Cancer Immunology, Immunotherapy.

[Treatment of methicillin-resistant Staphylococcus aureus (MRSA) as part of biosurgical management of a chronic leg ulcer].

S. Wagner, S. Esser, J. Dissemond, 2002, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

The role of tumor microenvironment in melanoma therapy resistance.

S. Wagner, M. Herlyn, R. Somasundaram, 2016, Melanoma management.

Venous leg ulcers in a patient with Klinefelter's syndrome and increased activity of plasminogen activator inhibitor-1.

S. Wagner, J. Dissemond, T. C. Brauns, 2003, Acta dermato-venereologica.

Association of TAP1 downregulation in human primary melanoma lesions with lack of spontaneous regression

S. Wagner, S. Ferrone, J. Dissemond, 2003, Melanoma research.

Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma.

S. Wagner, S. Koller, J. Smolle, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group

A. Hauschild, D. Schadendorf, S. Wagner, 2008, Melanoma research.

Targeting CD20 in melanoma patients at high risk of disease recurrence.

S. Wagner, M. Herlyn, G. Karanikas, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Induction of targeted cell migration by cutaneous administration of a DNA vector encoding a biologically active chemokine CCL21.

S. Wagner, E. Kriehuber, G. Stingl, 2010, The Journal of investigative dermatology.

A slow-cycling subpopulation of melanoma cells with highly invasive properties

Sydney M. Shaffer, K. Bennett, A. Raj, 2017, Oncogene.

Inhibition of CRM1-mediated nucleocytoplasmic transport: triggering human melanoma cell apoptosis by perturbing multiple cellular pathways.

S. Wagner, G. Pathria, C. Wagner, 2012, The Journal of investigative dermatology.

Alterations of ΔTA‐p 73 splice transcripts during melanoma development and progression

B. Pützer, S. Wagner, S. Tuve, 2004, International journal of cancer.

Combining filter-aided sample preparation and pseudoshotgun technology to profile the proteome of a low number of early passage human melanoma cells.

K. Bennett, S. Wagner, A. Müller, 2013, Journal of proteome research.

Dual c‐Jun N‐terminal kinase–cyclin D1 and extracellular signal‐related kinase–c‐Jun disjunction in human melanoma

S. Wagner, B. Garg, G. Pathria, 2016, The British journal of dermatology.

Immune response against human primary malignant melanoma: a distinct cytokine mRNA profile associated with spontaneous regression.

J. Becker, S. Wagner, C. Wagner, 1998, Laboratory investigation; a journal of technical methods and pathology.

Ras gene mutations: a rare event in nonmetastatic primary malignant melanoma.

H. Höfler, S. Wagner, H. Ockenfels, 1995, The Journal of investigative dermatology.

Inhibition of CRM1-Mediated Nucleocytoplasmic Transport: A New Approach to Trigger Human Melanoma Cell Apoptosis by Perturbing Multiple Cellular Pathways

S. Wagner, G. Pathria, C. Wagner, 2012 .

CD44 variant isoform v10 is expressed on tumor‐infiltrating lymphocytes and mediates hyaluronan‐independent heterotypic cell–cell adhesion to melanoma cells

S. Wagner, C. Wagner, M. Goos, 2003, Experimental dermatology.

EMPACT syndrome

S. Wagner, W. Pickl, G. Stingl, 2005, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Activated neutrophils exert antitumor activity against human melanoma cells: reactive oxygen species-induced mechanisms and their modulation by granulocyte-macrophage-colony-stimulating factor.

S. Wagner, K. Scharffetter-Kochanek, A. Schneeberger, 2003, The Journal of investigative dermatology.

[Surgical therapy of malignant melanoma of the external ear].

S. Wagner, R. Kling, P. Dost, 2004, HNO.

A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF

G. Superti-Furga, K. Bennett, S. Wagner, 2014, Oncogene.

RanBP3 Regulates Melanoma Cell Proliferation via Selective Control of Nuclear Export.

S. Wagner, B. Garg, G. Pathria, 2015, The Journal of investigative dermatology.

CAF variants control the tumor-immune microenvironment and predict skin cancer malignancy

S. Wagner, M. Kasper, J. Griss, 2023, bioRxiv.

Hyaluronan-independent adhesion of CD44H+ and CD44v10+ lymphocytes to dermal microvascular endothelial cells and keratinocytes.

S. Wagner, C. Wagner, M. Goos, 2001, The Journal of investigative dermatology.

Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes.

U. Reinhold, S. Wagner, M. Zöller, 1998, The Journal of investigative dermatology.

Erratum: Corrigendum: High-throughput oncogene mutation profiling in human cancer

S. Gabriel, S. Nelson, M. Meyerson, 2007 .

[The role of oxidative stress in the pathogenesis and therapy of chronic wounds].

S. Wagner, J. Dissemond, M. Goos, 2002, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Lithium and psoriasis: cytokine modulation of cultured lymphocytes and psoriatic keratinocytes by lithium

S. Wagner, H. Ockenfels, M. Goos, 1996, Archives of Dermatological Research.

Immunoproteasome subunits LMP2 and LMP7 downregulation in primary malignant melanoma lesions: association with lack of spontaneous regression

S. Wagner, S. Ferrone, J. Dissemond, 2003, Melanoma research.

Anaphylactic reaction to carboplatin diagnosed by skin testing—a reliable tool in platinum-based immediate-type hypersensitivity reactions

S. Wagner, A. Jalili, T. Kinaciyan, 2022, Wiener Medizinische Wochenschrift.

The effect of cyclosporin A and FK 506 on the cAMP content in psoriatic keratinocytes.

S. Wagner, H. Ockenfels, M. Goos, 1996, Skin pharmacology : the official journal of the Skin Pharmacology Society.

HLA Class I expression in uveal melanoma

S. Wagner, N. Bornfeld, G. Anastassiou, 2002 .

Melanoma genome sequencing reveals frequent PREX2 mutations

Trevor J Pugh, T. Fennell, A. Sivachenko, 2012, Nature.

MTSS1 is a metastasis driver in a subset of human melanomas

L. Chin, A. Sboner, K. Mertz, 2014, Nature Communications.

Pimecrolimus (SDZ ASM 981)

S. Wagner, J. Dissemond, M. Goos, 2002, Deutsche medizinische Wochenschrift.

Immunotargeting of tumor subpopulations in melanoma patients

S. Wagner, M. Herlyn, R. Somasundaram, 2012, Oncoimmunology.

Expression of classic and nonclassic HLA class I antigens in uveal melanoma.

S. Wagner, N. Bornfeld, G. Anastassiou, 2003, Investigative ophthalmology & visual science.